Lincoln Pharmaceuticals is currently trading at Rs. 116.60, up by 6.05 points or 5.47% from its previous closing of Rs. 110.55 on the BSE.
The scrip opened at Rs. 115.50 and has touched a high and low of Rs. 119.00 and Rs. 115.50 respectively. So far 63,000 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 119.00 on 30-Jul-2015 and a 52 week low of Rs. 33.60 on 31-Jul-2014.
Last one week high and low of the scrip stood at Rs. 119.00 and Rs. 99.00 respectively. The current market cap of the company is Rs. 189.00 crore.
The promoters holding in the company stood at 36.54% while Institutions and Non-Institutions held 0.01% and 63.45% respectively.
Lincoln Pharmaceuticals has decided to make further investment in Lincoln Parenteral, a subsidiary company, by acquiring 36.58% additional equity to get the additional manufacturing facility for Injectable and Liquids syrups, so that the company has complete range of products under therapeutic group like Tablet, Capsule, Ointment, Injectable, Syrup, Dry Powder under Lincoln Pharmaceuticals.
As a result of the additional investment, the total stake in the Lincoln Parenteral shall be 98.58% in the capital of the company. This investment will definitely increase the turn over and bottom line of the company.
Lincoln Pharmaceuticals is a company is based at Ahmedabad and engaged in Manufacturing and Export of Pharmaceuticals formulations under various Therapeutic product group, plant duly complied with WHO-GMP guidelines. The Company is exporting more than 45 countries along with Domestic market in more than 20 states in India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |